Skip to main content
. 2023 Jan 10;13:1063002. doi: 10.3389/fimmu.2022.1063002

Table 1.

CH1-CL mutations that favor the formation of cognate heavy-light pairing over mispairing. The CH1-CL of pertuzumab and DL11 are referred as CH1′-CL′ and CH1′′-CL′′, respectively.

Pertuzumab Q123D, N136D (CL′) L133V, L150A (CH1′)
DL11 Q123K, N136K, T177A (CL′′) K152D, H173D, S188W (CH1′′)